Hyperlipidemia in a myeloma patient after bortezomib treatment

Leuk Res. 2010 Sep;34(9):e250. doi: 10.1016/j.leukres.2010.03.025. Epub 2010 Apr 3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Boronic Acids / adverse effects*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Humans
  • Hyperlipidemias / chemically induced*
  • Multiple Myeloma / drug therapy*
  • Pyrazines / adverse effects*
  • Pyrazines / therapeutic use

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib